Showing Green!!Canopy is looking like it has some jump along with Terrascend, Tilray is up nicely as well. Acreage doesn't look like there will be much info there until all ducks are in a row....they have been held back so far and as all issues are resolved and Gov has their act together, Acreage is going to generate some serious volume and has a healthy clientele list on the med side but hamstrung by the lack of legalization by the Gov. As laws, that are to be changing to addess the sector are underway in most States the Regs will be be defined by State and on to the Feds??
They will need to have this all up and running, ready to take over the demand as cartels are sent to the house. They need borders controlled and managed for the illegal alien control/ management for the long term....they will need legal production and supply up and running asap in order to have a prayer of success of maintaining the control and mangement necessary overall and the borders especially. This will deal with the fentanyl attack underway already??
They will be able to limit/ control illegal human traffic as well going forward of which should have been well underway before this...but will be as many are assessing daily now!!
Legal cannabis is the best tool, along with appropriate management in place for the control of illegal activity 'in country'. The systems can be readied and the level of control required to manage and clean up the trash in the industry now and maintain all necessary laws in very short order with minimal effort if they have the planning and prep that they should have done by now,
The US has all the assets required to control illegal drugs and aliens from here and going forward and this needs to be implented, like yesterday!! The borders are key today as well 'killer' drugs but the basics are the same or close to the same, to get the work required done.
We need to see that pipe charged and oil flowing again the keep it all moving forward. A year from now the folks will have their country/ life back only much better and all round. JMHO...Opt
Key Metrics as of 26 Jan 2024 Metrics Earnings Yield (%) -790.9 Sales Yield (%) 1.3 Book Value Yield (%) 121.6 Returnon Assets (%)* -31.8 Revenue(Mil)* 228.1 Market Value (Mil) 17.3 Enterprise Value (Mil) 257.7 EVMVRatio 14.9 Volatility TTM (%) 119.7 Drawdown TTM (%) 76.0 Volume(K) 83.3 *30Sep 2023 Percentile in Sector 6.0 98.0 86.0 36.0 68.0 24.0 57.0 98.0 87.0 84.0 32.0 0% 25 50 75 100 Economic Moat History as of 31 Jan 2024 0.0 1.0 0.5 Wide Moat 0.99-1.00 Narrow Moat 0.71-0.99 No Moat 0.00-0.70 2019 2020 2021 2022 2023 Business Description Acreage Holdings Inc is a vertically integrated, multi-state operator in the cannabis industry. Its business operations include cultivating, processing, distributing, and retailing cannabis. The Company derives its revenues from its retail dispensary busi- ness, where cannabis and cannabis-infused products are sold to consumers. Its geographic segments include New England, Mid-Atlantic, Mid- west, West, and South. The Company operates un- der one operating segment, which is: the produc- tion and sale of cannabis products. Valuation as of 31 Jan 2024 Morningstar affirms a 3-star quantitative rating for Acreage Holdings. We calculate this outcome us- ing the company's underlying model-driven valu- ation and uncertainty scores. The stock's last closing price was 0.15, a discount of 54.22% to its Quantitative Fair Value estimate of 0.32. This discount has ranged between 76.66% and 42.17% over the past year. The stock's price to fair value ratio is at the 11th percentile in our glob- al equity coverage universe for this methodology and at the 19th percentile relative to its peers in the healthcare sector. Acreage Holdings furthermore holds a Extreme quantitative uncertainty rating. The company's quantitative star rating remains un- changed over the past year. Similarly, the firm's un- certainty rating has not changed during this period. We examine the financials and market statistics for Acreage Holdings to determine these ratings. Its enterprise value-to-market value ratio is 15.41 and its annualized trailing 12-month volatility is 119.43%. These fall at the 95th and 94th percent- iles in the equity universe and at the 95th and 86th in the healthcare sector, respectively. Economic Moat as of 31 Jan 2024 Quantitatively, we do not believe Acreage Holdings has an economic moat. Its moat score of 0.21 cor- responds to the 17th percentile in the healthcare sector. Furthermore, this rating has not changed over the past year, while the company's moat score fell from its maximum of 0.59 in this period (score of 1 indicates greatest economic moat). The company also maintains a quantitative finan- cial health rating of Weak. Its score sits at the 5th percentile in both the universe and sector. Examining the company's financials and market statistics, we find these ratings are principally driv- en by its book value yield and annualized trailing 12-month volatility. The book value yield is 126.11%, sitting at the 86th percentile in the healthcare sector. The company's annualized trail- ing 12-month volatility is 119.43%, corresponding to the 94th percentile in the equity coverage uni- verse and the 86th percentile in the sector. Fundamentalsas of 31 Jan 2024 Acreage Holdings maintains losses per share of - 1.21. The company further earns a return on inves- ted capital of -32.29%. These values are calculated over a trailing 12-month period. Contact 450 Lexington Avenue, New York, NY 10163 +1 646 600-9181 — https://www.acreageholdings.com Quantitative Equity Research Report | Release: 1 Feb 2024, 03:53 UTC | Reporting Currency: USD | Trading Currency: USD | Exchange: CANADIAN SECURITIES EXCHANGE ©2024 Morningstar. All Rights Reserved. Unless otherwise provided in a separate agreement, you may use this report only in the country in which its original distributor is based. The information, data, analyses and opinions presented herein do not constitute investment advice; are provided solely for informational purposes and therefore is not an offer to buy or sell a security; are not warranted to be correct, complete or accurate; and are subject to change without notice. Except as otherwise required by law, Morningstar shall not be responsible for any trading decisions, damages or other losses resulting from, or related to, the information, data, analyses or opinions or their use. The information herein may not be reproduced, in any manner without the prior written consent of Morningstar. Please see important disclosures at the end of this report.